Table 3 |
||||
|
Clinicopathological risk factors classified according to liver metastasis |
||||
|
Risk factors |
Liver Metastasis |
P* |
||
|
|
||||
|
n |
Negative |
Positive |
||
|
|
||||
|
Gender |
||||
|
Male |
247 |
182 |
65 |
0.939 |
|
Female |
108 |
80 |
28 |
|
|
Age |
||||
|
≤ 55 |
54 |
22 |
32 |
< 0.001 |
|
> 55 |
301 |
240 |
61 |
|
|
Tumour localization |
||||
|
Rectum |
203 |
150 |
53 |
0.965 |
|
Colon |
152 |
112 |
40 |
|
|
Tumour size (cm) |
||||
|
≤ 5 |
120 |
102 |
18 |
0.001 |
|
> 5 |
235 |
160 |
75 |
|
|
Type of tumour |
||||
|
Adenocarcinoma |
299 |
232 |
67 |
0.002 |
|
Mucinous adenocarcinoma |
31 |
17 |
14 |
|
|
Signet-ring cell carcinoma |
16 |
9 |
7 |
|
|
Undifferentiated carcinoma |
9 |
4 |
5 |
|
|
Tumour cell differentiation |
||||
|
Well/moderately differentiated |
279 |
236 |
43 |
< 0.001 |
|
Poorly differentiated |
76 |
26 |
50 |
|
|
Tumour invasion depth |
||||
|
T1 |
5 |
5 |
0 |
0.002 |
|
T2 |
63 |
20 |
1 |
|
|
T3 |
252 |
221 |
72 |
|
|
T4 |
35 |
25 |
20 |
|
|
Lymph node metastasis |
||||
|
< 4 |
123 |
104 |
19 |
0.001 |
|
≥ 4 |
232 |
158 |
74 |
|
|
Nuclear beta-catenin expression in SLN(s) |
||||
|
≤ 50% |
254 |
231 |
23 |
< 0.001 |
|
> 50% |
101 |
31 |
70 |
|
|
|
||||
|
* P value is the result of χ2 test in the same factor, and < 0.05 is considered statistically significant. |
||||
|
Cheng et al. Diagnostic Pathology 2011 6:109 doi:10.1186/1746-1596-6-109 |
||||
